Skip to main content
Top
Published in: European Journal of Nutrition 2/2021

Open Access 01-03-2021 | Nutrition | Original Contribution

Serum choline in extremely preterm infants declines with increasing parenteral nutrition

Authors: Anders K. Nilsson, Anders Pedersen, Daniel Malmodin, Anna-My Lund, Gunnel Hellgren, Chatarina Löfqvist, Ingrid Hansen Pupp, Ann Hellström

Published in: European Journal of Nutrition | Issue 2/2021

Login to get access

Abstract

Purpose

Choline is an essential nutrient for fetal and infant growth and development. Parenteral nutrition used in neonatal care lack free choline but contain small amounts of lipid-bound choline in the form of phosphatidylcholine (PC). Here, we examined the longitudinal development of serum free choline and metabolically related compounds betaine and methionine in extremely preterm infants and how the concentrations were affected by the proportion of parenteral fluids the infants received during the first 28 postnatal days (PNDs).

Methods

This prospective study included 87 infants born at gestational age (GA) < 28 weeks. Infant serum samples were collected PND 1, 7, 14, and 28, and at postmenstrual age (PMA) 32, 36, and 40 weeks. The serum concentrations of free choline, betaine, and methionine were determined by 1H NMR spectroscopy.

Results

The median (25th–75th percentile) serum concentrations of free choline, betaine, and methionine were 33.7 (26.2–41.2), 71.2 (53.2–100.8), and 25.6 (16.4–35.3) µM, respectively, at PND 1. The choline concentration decreased rapidly between PND one and PND seven [18.4 (14.1–26.4) µM], and then increased over the next 90 days, though never reaching PND one levels. There was a negative correlation between a high intake of parenteral fluids and serum-free choline.

Conclusion

Circulating free choline in extremely preterm infants is negatively affected by the proportion of parenteral fluids administered.

Trial registration

ClinicalTrials.gov Identifier NCT02760472, April 29, 2016, retrospectively registered.
Appendix
Available only for authorised users
Literature
7.
go back to reference Zeisel SH, Da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A (1991) Choline, an essential nutrient for humans. FASEB J 5(7):2093–2098CrossRef Zeisel SH, Da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A (1991) Choline, an essential nutrient for humans. FASEB J 5(7):2093–2098CrossRef
11.
go back to reference Buchman AL, Sohel M, Moukarzel A, Bryant D, Schanler R, Awal M, Burns P, Dorman K, Belfort M, Jenden DJ, Killip D, Roch M (2001) Plasma choline in normal newborns, infants, toddlers, and in very-low-birth-weight neonates requiring total parenteral nutrition. Nutrition 17(1):18–21CrossRef Buchman AL, Sohel M, Moukarzel A, Bryant D, Schanler R, Awal M, Burns P, Dorman K, Belfort M, Jenden DJ, Killip D, Roch M (2001) Plasma choline in normal newborns, infants, toddlers, and in very-low-birth-weight neonates requiring total parenteral nutrition. Nutrition 17(1):18–21CrossRef
16.
go back to reference Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME, Eckhert CD (1992) Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 102(4 Pt 1):1363–1370CrossRef Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME, Eckhert CD (1992) Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 102(4 Pt 1):1363–1370CrossRef
17.
go back to reference Buchman AL, Ament ME, Sohel M, Dubin M, Jenden DJ, Roch M, Pownall H, Farley W, Awal M, Ahn C (2001) Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. JPEN J Parenter Enteral Nutr 25(5):260–268. https://doi.org/10.1177/0148607101025005260CrossRefPubMed Buchman AL, Ament ME, Sohel M, Dubin M, Jenden DJ, Roch M, Pownall H, Farley W, Awal M, Ahn C (2001) Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. JPEN J Parenter Enteral Nutr 25(5):260–268. https://​doi.​org/​10.​1177/​0148607101025005​260CrossRefPubMed
18.
go back to reference Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K, Ament ME (1993) Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr 12(1):33–37CrossRef Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K, Ament ME (1993) Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr 12(1):33–37CrossRef
28.
go back to reference Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vazquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, Sayeeda Z, Lo E, Assempour N, Berjanskii M, Singhal S, Arndt D, Liang Y, Badran H, Grant J, Serra-Cayuela A, Liu Y, Mandal R, Neveu V, Pon A, Knox C, Wilson M, Manach C, Scalbert A (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46(D1):D608–d617. https://doi.org/10.1093/nar/gkx1089CrossRefPubMed Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vazquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, Sayeeda Z, Lo E, Assempour N, Berjanskii M, Singhal S, Arndt D, Liang Y, Badran H, Grant J, Serra-Cayuela A, Liu Y, Mandal R, Neveu V, Pon A, Knox C, Wilson M, Manach C, Scalbert A (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46(D1):D608–d617. https://​doi.​org/​10.​1093/​nar/​gkx1089CrossRefPubMed
29.
go back to reference Wickham H (2016) ggplot2: elegant graphics for data analysis. Springer-Verlag, New YorkCrossRef Wickham H (2016) ggplot2: elegant graphics for data analysis. Springer-Verlag, New YorkCrossRef
Metadata
Title
Serum choline in extremely preterm infants declines with increasing parenteral nutrition
Authors
Anders K. Nilsson
Anders Pedersen
Daniel Malmodin
Anna-My Lund
Gunnel Hellgren
Chatarina Löfqvist
Ingrid Hansen Pupp
Ann Hellström
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Keyword
Nutrition
Published in
European Journal of Nutrition / Issue 2/2021
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02312-2

Other articles of this Issue 2/2021

European Journal of Nutrition 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.